NEU 2.37% $19.39 neuren pharmaceuticals limited

I guess the US$7.3 billion enterprise value of this acquisition...

  1. 43 Posts.
    lightbulb Created with Sketch. 35
    I guess the US$7.3 billion enterprise value of this acquisition implies that Acadia’s global rights for Daybue are worth the same, meaning Acadia is worth $44.90 per share in a takeout for its Daybue rights, excluding the rest of its pipeline. Acadia is now trading at or about US$28.30. What takeout value can be interpolated for Neuren from this acquisition? Probably too soon to tell prior to impending phase 2 results.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.39
Change
-0.470(2.37%)
Mkt cap ! $2.478B
Open High Low Value Volume
$19.70 $19.77 $19.28 $10.38M 534.0K

Buyers (Bids)

No. Vol. Price($)
3 2680 $19.35
 

Sellers (Offers)

Price($) Vol. No.
$19.41 362 1
View Market Depth
Last trade - 16.10pm 30/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.